Daily non-political popular news in brief.
One-fifth of patients in drug-free remission following early treatment with Infliximab and Methotrex
06-14-2007 · EurekAlert!Early treatment with a combination of methotrexate and infliximab may be effective as remission induction therapy and alter the course of early rheumatoid arthritis, according to data presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.
Read more »
Keywords: one-fifth, patients, drug-free, remission, following, treatment, infliximab, methotrex, one, fifth, patient, drug, free
« Previous | Next »
Similar news on "One-fifth of patients in drug-free remission following early treatment with Infliximab and Methotrex":
- 1/5 of patients in drug-free remission following early treatment with Infliximab and Methotrex
06-14-2007 · EurekAlert!
Early treatment with a combination of methotrexate and infliximab may be effective as remission induction therapy and alter the course of early rheumatoid arthritis, according to data presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.
Similar news · Read more »
- UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
01-31-2008 · EurekAlert!
Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.
Similar news · Read more »
- Studies led by Rhode Island Hospital confirm safety and efficacy
11-17-2006 · EurekAlert!
Following two studies of patients who were treated with cardiac stents, physicians at Rhode Island Hospital continue to recommend drug-eluting stents as a safe and effective treatment.
Similar news · Read more »
- Bronchial thermoplasty may allow severe asthma patients to wean off oral corticosteroids
05-23-2007 · EurekAlert!
Positive results from the Research in Severe Asthma (RISA) Trial of Bronchial Thermoplasty were reported today at the annual scientific assembly of the American Thoracic Society (ATS). Clinically and statistically significant improvements in pulmonary function, asthma control, and quality of life, as well as a reduction in use of rescue medications, were observed following the bronchial thermoplasty procedure in patients with severe asthma. Bronchial Thermoplasty is first non-drug treatment for asthma.
Similar news · Read more »
- Aggressive therapy best for certain AML patients
08-01-2007 · EurekAlert!
A new study suggests that acute leukemia patients whose cancer cells show a genetic change that usually predicts a swift return of the disease following remission may remain disease-free longer when given aggressive therapy. The findings apply to people with acute myeloid leukemia whose cancer cells have normal-looking chromosomes and a gene mutation called MLL-PTD.
Similar news · Read more »
- Data show treatment with Remicade reduced hospitalizations for ulcerative colitis patients by half
10-23-2006 · EurekAlert!
Patients with UC treated with Remicade® (infliximab) had an approximate 50 percent reduction in mean number of hospitalizations per year compared with placebo, according to an analysis of long-term data from a Phase 3 clinical trial presented at the ACG meeting. Patients who responded and those who were in remission at one year had lower mean number of hospitalizations vs. non-responders through one year of treatment.
Similar news · Read more »
- Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone
10-10-2007 · EurekAlert!
Getting the drug dosage correct can be a tricky exercise in trial and error in a disease like multiple sclerosis. Scientists from the Weizmann Institute and the Technion have identified two genes that affect a patient's response to the drug Copaxone, a finding which may help take the some of the guesswork out of treatment.
Similar news · Read more »
- Mayo Clinic Cancer Center -- individualizing treatment for multiple myeloma patients
12-10-2006 · EurekAlert!
Researchers at Mayo Clinic Cancer Center, in cooperation with industry partners, have, for the first time, identified tumor specific alterations in the cellular pathway by which the multiple myeloma drug bortezomib (Velcade) works, and they have identified nine new genetic mutations in cancer cells that should increase a patient's chance of responding to the agent.
Similar news · Read more »
- Infliximab scheduled treatment has proven to be an effective strategy in IBD patients
10-25-2007 · EurekAlert!
Although many drugs have been used in the treatment of inflammatory bowel disease, none have yet been shown to modify the natural history of the diseases or to maintain a stable remission over time. The introduction of biological agents in the therapeutic armamentarium for Crohn's disease and ulcerative colitis has significantly changed the treatment strategies and outcomes of patients. Infliximab scheduled treatment has proven to be an effective strategy in IBD patients for long-term maintenance of clinical remission.
Similar news · Read more »
- Annals of Internal Medicine tip sheet for March 20, 2007
03-19-2007 · EurekAlert!
The following articles are featured in the upcoming Annals of Internal Medicine: "Flexible Use of Drugs with Close Patient Follow-up Can Successfully Control Rheumatoid Arthritis;" "Osteoporosis Drug Strengthens Bones in Men with Prostate Cancer," and "Experts Show Physicians How to Initiate and Carry Through Timely and Effective Discussions about Hospice with Dying Patients."
Similar news · Read more »
